Clinical Trials of ARB and ACE-I on Nephropathy in Type 2 Diabetes | Download Table
ACE Inhibitors or ARBs for Prevention of Type 2 Diabetes: A Meta-analysis of Randomized Clinical Trials
Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome | Journal of Translational Medicine | Full Text
Diabetes and Chronic Kidney Disease: Tragedy and Challenge | Semantic Scholar
Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria | Hypertension
Does Everyone with Diabetes Need to Be on an ACE Inhibitor? - Taking Control Of Your Diabetes®
Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research
NKF KDOQI Guidelines
ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine
Physician Conformity and Patient Adherence to ACE Inhibitors and ARBs in Patients With Diabetes, With and Without Renal Disease
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
![PDF] Physician Conformity and Patient Adherence to ACE Inhibitors and ARBs in Patients With Diabetes , With and Without Renal Disease and Hypertension , in a Medicaid Managed Care Organization | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/904699249549d3a4a89d256683f1d85e237a1bc6/5-Figure2-1.png "PDF] Physician Conformity and Patient Adherence to ACE Inhibitors and ARBs in Patients With Diabetes , With and Without Renal Disease and Hypertension , in a Medicaid Managed Care Organization | Semantic Scholar")
PDF] Physician Conformity and Patient Adherence to ACE Inhibitors and ARBs in Patients With Diabetes , With and Without Renal Disease and Hypertension , in a Medicaid Managed Care Organization | Semantic Scholar
IJMS | Free Full-Text | Glucose and Blood Pressure-Dependent Pathways–The Progression of Diabetic Kidney Disease
DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment | Hypertension
An Overview of Generic Angiotensin Receptor Blockers
The RAAS in the pathogenesis and treatment of diabetic nephropathy | Nature Reviews Nephrology
ACE inhibitors or ARBs for diabetic nephropathy: the unrelenting debate. | Semantic Scholar
ACE-inhibitors/ARBs in diabetics: Evidence doesn't support the CDA guidelines | Dr. Mario Elia
Diabetic Kidney Disease – edren.org
ACE Inhibitors or ARBs to Prevent CKD in Patients with Microalbuminuria | AAFP
NKF KDOQI Guidelines
Should ACE-inhibitors and ARBs be stopped with COVID-19? — NephJC
Prioritization Tools— ACEI/ARB Case Study - Evaluating the Potential Use of Modeling and Value-of-Information Analysis for Future Research Prioritization Within the Evidence-Based Practice Center Program - NCBI Bookshelf
